Showing results (51-60 of 365) with videos related to
Sort By:
Pageof 37
Hepatology (Baltimore, Md.)|September 22, 2007
Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndromeFlorence Wong, Kevin Moore, Jasper Dingemanse, et al.Seminars in Liver Disease|February 23, 2008
Artificial liver support systems in the management of complications of cirrhosisVanessa Stadlbauer, Nathan A Davies, Sambit Sen, et al.Plos One|August 18, 2015
Mathematical Model of Ammonia Handling in the Rat Renal MedullaLorette Noiret, Stephen Baigent, Rajiv Jalan, et al.Metabolic Brain Disease|May 20, 2014
The brain in acute on chronic liver failureGavin Wright, Yalda Sharifi, Maria Jover-Cobos, et al.Metabolic Brain Disease|March 5, 2013
Ornithine phenylacetate revisitedMaria Jover-Cobos, Lorette Noiret, Yalda Sharifi, et al.Clinics in Liver Disease|September 15, 2006
Acute liver failure: a reviewShahid A Khan, Naina Shah, Roger Williams, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 8, 2014
Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failureGautam Mehta, Rajeshwar P Mookerjee, Vikram Sharma, et al.Seminars in Nephrology|January 5, 2019
Epidemiology, Pathophysiology, and Management of Hepatorenal SyndromeAhmed Adel Amin, Eman Ibrahim Alabsawy, Rajiv Jalan, et al.Alimentary Pharmacology & Therapeutics|June 24, 2020
MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascitesPeter Jepsen, Hugh Watson, Stewart Macdonald, et al.Pageof 37